MedTrace Logo

Efficacy Evaluation of the Mushroom Beverage on Emotion Regulation

NCT04002219 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2022-10-10

No results posted yet for this study

Summary

Major Depression Disorder is one of the most common psychiatric disease and has affecting approximately 350 million people in the world. According to World Health Organization's report, it may be the first burden of disease in 2030. Due to the high morbidity and low acceptance in the treatment, it is necessary to find some nature compounds to prevent the disease.

Cordyceps militaris, one of the most treasure Chinese herbs in Asia, contains many kinds of component such as cordycepin, polysaccharide, mannitol. In winter, it appears as an worm in the soil, afterwards, it grows out of the soil and convert into grass in summer. A previous study has demonstrated that Cordyceps militaris has anti-depressive effect in mouse tail suspension test, and in this study we will explore its effect in human subjects.

Conditions

  • Inflammation, Brain
  • Emotional Problem

Interventions

DIETARY_SUPPLEMENT

beverage containing mushroom-extracts

Subjects recruited from both arms will receive treatment and be followed up clinically for 8 weeks.

Sponsors & Collaborators

  • National Taiwan University

    collaborator OTHER

  • National Science and Technology Council, Taiwan

    lead OTHER_GOV

Principal Investigators

  • Kuan-Pin Su, MD, PhD · China Medical University, China

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-01
Primary Completion
2019-12-31
Completion
2020-02-28

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04002219 on ClinicalTrials.gov